Recent advances in understanding the molecular mechanisms of tamoxifen action.
Friedman
Z Y
ZY
Department of Biological Chemistry, Hebrew University of Jerusalem, Israel.
D019870:1-Phosphatidylinositol 4-Kinase / Q000378:metabolism; D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism; D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology*; D000975:Antioxidants / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects; D002147:Calmodulin / Q000037:antagonists & inhibitors / Q000378:metabolism; D018432:Drug Resistance, Multiple; D004789:Enzyme Activation; D006801:Humans; D011493:Protein Kinase C / Q000037:antagonists & inhibitors* / Q000378:metabolism; D013629:Tamoxifen / Q000494:pharmacology*; D010738:Type C Phospholipases / Q000037:antagonists & inhibitors / Q000378:metabolism
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D018931:Antineoplastic Agents, Hormonal; D000975:Antioxidants; D002147:Calmodulin; D013629:Tamoxifen; D019870:1-Phosphatidylinositol 4-Kinase; D011493:Protein Kinase C; D010738:Type C Phospholipases